Patent Yard Sign in
Canadian application, no grantCanada

Human ion-exchanger proteins and polynucleotides encoding the same

CA 2423942 A1 · Owner: Friddle, Carl Johan · Inventors: Gerhardt, Brenda; Friddle, Carl Johan

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomicapplications.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 24, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 24, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 24, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 24, 2001
GrantedNo grant recorded
Term endedSeptember 24, 2021
Patent numberCA 2423942 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedSep 24, 2001Term endedSep 24, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.